Linked Data API

Show Search Form

Search Results

1134907
star this property registered interest false more like this
star this property date less than 2019-06-26more like thismore than 2019-06-26
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading 100,000 Genomes Project more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans his Department has to evaluate the 100,000 Genomes Project. more like this
star this property tabling member constituency Birmingham, Yardley more like this
star this property tabling member printed
Jess Phillips more like this
star this property uin 269788 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-05more like thismore than 2019-07-05
star this property answer text <p>As a Government Major Project, the 100,000 Genomes Project has been under regular review by the Infrastructure and Projects Authority (IPA) which provides independent assurance of the most complex and strategically significant projects across Government. As part of this, the 100,000 Genomes Project has undergone several significant reviews which considered the Project’s delivery, requiring the collation of extensive documentation evidencing the progress of the Project and several days of interviews with key stakeholders. Conclusions of each review were shared across delivery partners to inform successful delivery of the Project.</p><p>The Department, Genomics England and NHS England recognised the importance in embedding robust testing, assessment and evaluation throughout the delivery of the Project to inform the introduction of whole genome sequencing in the National Health Service under the new Genomics Medicine Service.</p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-05T11:40:47Zmore like thismore than 2019-07-05T11:40:47Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4370
unstar this property label Biography information for Jess Phillips more like this
1134018
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268506 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134019
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268507 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134020
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268508 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134021
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268509 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1134022
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how the Accelerated Access Collaborative plans to balance its focus on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 268510 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-02more like thismore than 2019-07-02
star this property answer text <p>There are no restrictions on the type of innovation that can be supported by the Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies, devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In October 2018, the AAC announced it was supporting to increased uptake and use of 12 high performing products, which span seven technology areas, in the National Health Service. Of the seven categories selected for support, two are medicines, four are diagnostic tests, and one is a device.</p><p>Further information about the products the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-02T16:06:55.223Zmore like thismore than 2019-07-02T16:06:55.223Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137416
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will list (a) the criteria and (b) the timelines for products to be considered in (i) the current and (ii) future review rounds of the Accelerated Access Collaborative. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 274540 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-15T15:23:36.753Zmore like thismore than 2019-07-15T15:23:36.753Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1137418
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Accelerated Access Collaborative more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what criteria the Accelerated Access Collaborative uses in relation to decision-making on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 274542 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.</p><p>When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p>Further information is available at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p><p> </p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-15T15:33:03.587Zmore like thismore than 2019-07-15T15:33:03.587Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
1136400
star this property registered interest false more like this
star this property date less than 2019-07-02more like thismore than 2019-07-02
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Air Pollution: Health Hazards more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what information his Department holds on studies carried out by the (a) National Institute for Health Research and (b) NHS Health Protection Research Unit into the effects on human health of (i) PM1 and (ii) PM0.1. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 272131 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-10more like thismore than 2019-07-10
star this property answer text <p>The Department invests over £1 billion a year in health research through the National Institute for Health Research (NIHR). The NIHR supports a wide range of work on the health effects of air pollution through various funding streams, including research on the impacts of fine particulate matter with a diameter of <em>2.5</em> μm or less (PM2.5). The majority of research commissioned is focussed on a wide range of pollutants and unless otherwise stated, most studies have not differentiated between PM2.5, PM1.0 and PM0.1.</p><p>Information on the research projects commissioned and their findings are published by the NIHR in a dedicated journals library which can be found at the following link:</p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-10T16:17:00.327Zmore like thismore than 2019-07-10T16:17:00.327Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this
1134829
star this property registered interest false more like this
star this property date less than 2019-06-26more like thismore than 2019-06-26
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Antimicrobials: Drug Resistance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what research his Department has undertaken (a) directly, (b) through research councils and (c) with international partners on antimicrobial resistance. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 269618 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-05more like thismore than 2019-07-05
star this property answer text <p>The Department is investing over £1 billion a year in health research through the National Institute for Health Research (NIHR). The NIHR supports a wide portfolio of research on antimicrobial resistance (AMR) through various funding streams. In the United Kingdom, investment includes £32 million of capital funding to support AMR research, £19.1 million for AMR research at four NIHR Biomedical Research Centres, and £8.8 million for two NIHR Health Protection Research Units on Healthcare Associated Infections and Antimicrobial Resistance.</p><p>The NIHR also supports research into AMR in low and middle-income countries (LMICs), with official development assistance (ODA) funding through the NIHR Global Health Research programme. Investment includes support for the NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance, and the NIHR Global Health Research Group on Genomic Surveillance of Malaria in West Africa.</p><p>Working through partnerships with other UK funders, the NIHR Global Health Research programme also supports cross-Research Council initiatives including one led by the Medical Research Council for research into AMR in a global context, and another led by the Economic and Social Research Council to expand understanding of how behaviour within and beyond the healthcare system impacts on AMR.</p><p>In addition, the Department has allocated over £50 million of ODA over five years to AMR research through the Global AMR Innovation Fund. This research is delivered through a range of mechanisms and delivery partners, including research councils such as the Biotechnology and Biological Sciences Research Council and Innovate UK, and international partners including the Wellcome Trust, Bill and Melinda Gates Foundation, the United States and German governments, and Canada’s International Development Research Centre.</p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage remove filter
star this property question first answered
less than 2019-07-05T11:34:34.067Zmore like thismore than 2019-07-05T11:34:34.067Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this